MedTrace Logo

Peripheral Nerve Ultrasound for Diagnosis and Prognosis of Guillain-Barre Syndrome

NCT04053452 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2025-05-09

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine if peripheral nerve ultrasound can be used as a supplemental tool to diagnose Guillain-Barre syndrome (GBS) in the acute setting and aid in prognostication.

Conditions

  • Guillain-Barre Syndrome

Interventions

DIAGNOSTIC_TEST

Peripheral nerve ultrasound

Ultrasound of the bilateral ulnar nerves, median nerves, vagus nerves, and C6 and C7 nerve roots will be performed.

DIAGNOSTIC_TEST

Measurement of strength

Strength will be assessed by physical examination and recorded using Medical Research Council (MRC) scale, and a hand dynamometer will be used to measure grip strength.

Sponsors & Collaborators

Principal Investigators

  • Lisa Hobson-Webb, M.D. · Duke University

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-30
Primary Completion
2023-07-04
Completion
2024-02-05
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04053452 on ClinicalTrials.gov